Navi Mumbai's Apollo Hospitals Hosts Blood Cancer Support Meet, Highlights Advances In CAR T-Cell Therapy And Survivorship Care
Navi Mumbai's Apollo Hospitals hosted a blood cancer support meet highlighting early diagnosis and advanced treatments like CAR T-cell therapy. Doctors emphasised survivorship care, while case studies showcased successful outcomes in complex and relapsed cases.

Apollo Hospitals In Navi Mumbai | File Photo
Navi Mumbai, April 25: A Blood Cancer Survivor Support Group Meeting organised by Apollo Hospitals Navi Mumbai brought together doctors, patients, and survivors to emphasise the importance of early diagnosis, evolving treatment approaches, and long-term care in blood cancers.
The initiative focused on creating a platform for shared experiences while highlighting recent breakthroughs improving outcomes in complex and relapsed cases.
Experts discuss diagnosis and access to care
The session was led by Dr Punit Jain and Dr Vipin Khandelwal, who addressed challenges in timely diagnosis and access to care, while also underlining the need for structured survivorship support for both adult and paediatric patients.
“One of the biggest challenges in blood cancers is delayed diagnosis as symptoms are often mistaken for routine illness. Early detection can significantly improve survival rates,” said Dr Jain, adding that advancements in bone marrow transplant, CAR T-cell therapy and immunotherapy are offering new hope even in relapsed cases.
Focus on survivorship and long-term care
Focusing on life after treatment, Dr Khandelwal stressed that survivorship care must extend beyond remission. “Ensuring good quality of life post-treatment is equally important. Long-term follow-up, monitoring of late effects, and psychosocial support are crucial, especially for children and their families,” he said.
Case studies highlight treatment success
The meeting also featured case studies demonstrating the impact of advanced therapies. In one case, a 54-year-old woman with Philadelphia chromosome-negative B-cell Acute Lymphoblastic Leukaemia achieved complete remission after a combination of chemotherapy, immunotherapy and CAR T-cell therapy, despite relapsing during treatment.
Also Watch:
ALSO READ
In another case, a six-year-old child with Acute Lymphoblastic Leukaemia who had suffered two relapses underwent targeted therapy followed by a haploidentical stem cell transplant using the father as donor. The child has remained in complete remission for over 200 days, marking a significant milestone in a high-risk case.
To get details on exclusive and budget-friendly property deals in Mumbai & surrounding regions, do visit: https://budgetproperties.in/
RECENT STORIES
-
'Well Behaved, Articulate Girl': Shaina NC Pens Heartfelt Note For Devendra & Amruta Fadnavis'... -
Nocil Shares Hit 20% Upper Circuit, Stock Surges ₹31.80 In Strong Single-Day Rally -
MLC 2026 Drama: Tempers Flare As Shubham Ranjane Collides With Keiron Pollard During MI New York Vs... -
'₹20 Ka Tha, ₹120 Le Liya': Bihar Student Gets Refund After Vendor Overcharges Chole Bhature At... -
Oppo Reno 16 Series Design Details Teased Ahead Of India Launch; Reno 16c Confirmed As Well
